Third View Private Wealth
AZN icon

Third View Private Wealth’s AstraZeneca AZN Stock Holding History

Third View Private Wealth’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.68M Buy
16,581
+376
+2% +$62.7K 0.32% 76
2026
Q2 		$3.07M Sell
16,205
-1,859
-10% -$350K 0.38% 63
2026
Q1 		$3.56M Buy
18,064
+2,018
+13% +$389K 0.49% 49
2025
Q4 		$2.95M Buy
+16,046
New +$2.81M 0.4% 63

Other funds holding AZN

Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $103B AUM 36.66% 1-Year Est. Return
SEB Asset Management
SEB Asset Management Stockholm $27B AUM
LBP AM
LBP AM Paris, France $11.2B AUM 34.48% 1-Year Est. Return
M&G plc
M&G plc London, United Kingdom $19.9B AUM 15.09% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Third View Private Wealth's AZN Position: Q3 2026 in Review

Third View Private Wealth increased its AstraZeneca (AZN) stake by 2.3% in Q3 2026, buying an estimated $62.7K and bringing the position to 16,581 shares worth $2.68M. The position accounts for 0.32% of the portfolio, ranked #76.

Third View Private Wealth first reported a position in AZN in Q4 2025 and has held it in 4 quarters since. The position peaked at $3.56M in Q1 2026. 782 funds tracked by Wall St. Rank hold AZN as of Q3 2026.

  • Third View Private Wealth held 16,581 shares of AstraZeneca worth $2.68M as of Q3 2026.
  • Third View Private Wealth bought 376 AstraZeneca shares in Q3 2026, an estimated $62.7K.
  • AstraZeneca made up 0.32% of Third View Private Wealth's portfolio in Q3 2026, its #76 holding.
  • Third View Private Wealth first reported a position in AstraZeneca in Q4 2025 and has held it in 4 quarters since.
  • Third View Private Wealth's AstraZeneca position peaked at $3.56M in Q1 2026.
  • 782 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.

Based on Third View Private Wealth's 13F filing for Q3 2026, filed 30 Oct 2026.